FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

765065005: Powder for suspension for infusion (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Jun 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3656250018 Powder for suspension for infusion en Synonym Active Entire term case insensitive SNOMED CT core module
3656251019 Powder for conventional release suspension for infusion en Synonym Active Entire term case insensitive SNOMED CT core module
3656252014 Powder for conventional release suspension for infusion (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1116671000001114 Powder for suspension for infusion (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom Edition module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Powder for suspension for infusion Is a Parenteral dose form true Inferred relationship Existential restriction modifier
Powder for suspension for infusion Has dose form administration method Infuse true Inferred relationship Existential restriction modifier
Powder for suspension for infusion Has dose form transformation Disperse true Inferred relationship Existential restriction modifier
Powder for suspension for infusion Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Powder for suspension for infusion Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Powder for suspension for infusion Has basic dose form Powder true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Paclitaxel albumin 100mg powder for suspension for infusion vials Has manufactured dose form False Powder for suspension for infusion Inferred relationship Existential restriction modifier
Mifamurtide 4mg powder for suspension for infusion vials Has manufactured dose form False Powder for suspension for infusion Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has manufactured dose form True Powder for suspension for infusion Inferred relationship Existential restriction modifier
Abraxane 100mg powder for suspension for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has manufactured dose form True Powder for suspension for infusion Inferred relationship Existential restriction modifier
Product containing precisely paclitaxel 100 milligram/1 vial powder for conventional release suspension for injection Has manufactured dose form False Powder for suspension for infusion Inferred relationship Existential restriction modifier
Mifamurtide 4mg powder for suspension for infusion vials 1 vial Has dispensed dose form True Powder for suspension for infusion Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Powder for suspension for infusion Inferred relationship Existential restriction modifier
Mifamurtide 4mg powder for suspension for infusion vials Has dispensed dose form True Powder for suspension for infusion Inferred relationship Existential restriction modifier
Mepact 4mg powder for suspension for infusion vials (Takeda UK Ltd) Has dispensed dose form True Powder for suspension for infusion Inferred relationship Existential restriction modifier
Abraxane 100mg powder for suspension for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Powder for suspension for infusion Inferred relationship Existential restriction modifier
Paclitaxel albumin 100mg powder for suspension for infusion vials Has dispensed dose form True Powder for suspension for infusion Inferred relationship Existential restriction modifier
Abraxane 100mg powder for suspension for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form True Powder for suspension for infusion Inferred relationship Existential restriction modifier
Paclitaxel albumin 100mg powder for suspension for infusion vials 1 vial Has dispensed dose form True Powder for suspension for infusion Inferred relationship Existential restriction modifier
Trastuzumab 420mg powder for solution for infusion vials Has dispensed dose form False Powder for suspension for infusion Inferred relationship Existential restriction modifier
Kanjinti 420mg powder for concentrate for solution for infusion vials (Amgen Ltd) Has dispensed dose form False Powder for suspension for infusion Inferred relationship Existential restriction modifier
Trastuzumab 420mg powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for suspension for infusion Inferred relationship Existential restriction modifier
Kanjinti 420mg powder for concentrate for solution for infusion vials (Amgen Ltd) 1 vial Has dispensed dose form False Powder for suspension for infusion Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start